Glaxo Grp Ltd Company Profile
✉ Email this page to a colleague
What is the competitive landscape for GLAXO GRP LTD, and when can generic versions of GLAXO GRP LTD drugs launch?
GLAXO GRP LTD has eight approved drugs.
There are twelve US patents protecting GLAXO GRP LTD drugs.
There are two hundred and thirty-four patent family members on GLAXO GRP LTD drugs in thirty-three countries and twenty-nine supplementary protection certificates in sixteen countries.
Summary for Glaxo Grp Ltd
International Patents: | 234 |
US Patents: | 12 |
Tradenames: | 13 |
Ingredients: | 4 |
NDAs: | 8 |
Drugs and US Patents for Glaxo Grp Ltd
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Glaxo Grp Ltd | FLOVENT HFA | fluticasone propionate | AEROSOL, METERED;INHALATION | 021433-001 | May 14, 2004 | RX | Yes | Yes | 7,832,351*PED | See Plans and Pricing | Y | See Plans and Pricing | |||
Glaxo Grp Ltd | ADVAIR DISKUS 500/50 | fluticasone propionate; salmeterol xinafoate | POWDER;INHALATION | 021077-003 | Aug 24, 2000 | AB | RX | Yes | Yes | See Plans and Pricing | See Plans and Pricing | ||||
Glaxo Grp Ltd | ZANTAC 150 | ranitidine hydrochloride | TABLET, EFFERVESCENT;ORAL | 020251-001 | Mar 31, 1994 | DISCN | No | No | See Plans and Pricing | See Plans and Pricing | |||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Glaxo Grp Ltd
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Glaxo Grp Ltd | ADVAIR HFA | fluticasone propionate; salmeterol xinafoate | AEROSOL, METERED;INHALATION | 021254-002 | Jun 8, 2006 | 6,161,724*PED | See Plans and Pricing |
Glaxo Grp Ltd | FLOVENT HFA | fluticasone propionate | AEROSOL, METERED;INHALATION | 021433-001 | May 14, 2004 | 6,253,762*PED | See Plans and Pricing |
Glaxo Grp Ltd | ADVAIR DISKUS 100/50 | fluticasone propionate; salmeterol xinafoate | POWDER;INHALATION | 021077-001 | Aug 24, 2000 | 6,536,427*PED | See Plans and Pricing |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Paragraph IV (Patent) Challenges for GLAXO GRP LTD drugs
Drugname | Dosage | Strength | Tradename | Submissiondate |
---|---|---|---|---|
➤ Subscribe | Tablets | 150 mg | ➤ Subscribe | 2007-10-30 |
International Patents for Glaxo Grp Ltd Drugs
Country | Patent Number | Estimated Expiration |
---|---|---|
Canada | 2489554 | See Plans and Pricing |
Poland | 1907037 | See Plans and Pricing |
Spain | 2421402 | See Plans and Pricing |
>Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for Glaxo Grp Ltd Drugs
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
1425001 | 14C0028 | France | See Plans and Pricing | PRODUCT NAME: VILANTEROL OU UN SEL OU UN SOLVATE DE CELUI-CI,EN PARTICULIER LE TRIFENATATE DE VILANTEROL.; REGISTRATION NO/DATE: EU/1/13/886/001-006 20131113 |
1425001 | C01425001/01 | Switzerland | See Plans and Pricing | PRODUCT NAME: VILANTEROL; REGISTRATION NO/DATE: SWISSMEDIC 62969 09.01.2014 |
1425001 | CA 2014 00021 | Denmark | See Plans and Pricing | PRODUCT NAME: VILANTEROL ELLER ET SALT ELLER SOLVAT DERAF, HERUNDER VILANTEROL TRIFENATAT; REG. NO/DATE: EU/1/13/886/001-006 20131113 |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Here is a list of applicants with similar names.